Carotid body chemoreceptors, sympathetic neural activation, and cardiometabolic disease

The carotid body (CB) is the main peripheral chemoreceptor that senses the arterial PO 2 , PCO 2 and pH. In response to hypoxemia, hypercapnia and acidosis, carotid chemosensory discharge elicits reflex respiratory, autonomic and cardiovascular adjustments. The classical construct considers the CB a...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Biological research Ročník 49; číslo 1; s. 13
Hlavní autori: Iturriaga, Rodrigo, Del Rio, Rodrigo, Idiaquez, Juan, Somers, Virend K.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: London BioMed Central 26.02.2016
BioMed Central Ltd
Springer Nature B.V
Predmet:
ISSN:0717-6287, 0716-9760, 0717-6287
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:The carotid body (CB) is the main peripheral chemoreceptor that senses the arterial PO 2 , PCO 2 and pH. In response to hypoxemia, hypercapnia and acidosis, carotid chemosensory discharge elicits reflex respiratory, autonomic and cardiovascular adjustments. The classical construct considers the CB as the main peripheral oxygen sensor, triggering reflex physiological responses to acute hypoxemia and facilitating the ventilatory acclimation to chronic hypoxemia at high altitude. However, a growing body of experimental evidence supports the novel concept that an abnormally enhanced CB chemosensory input to the brainstem contributes to overactivation of the sympathetic nervous system, and consequent pathology. Indeed, the CB has been implicated in several diseases associated with increases in central sympathetic outflow. These include hypertension, heart failure, sleep apnea, chronic obstructive pulmonary disease and metabolic syndrome. Indeed, ablation of the CB has been proposed for the treatment of severe and resistant hypertension in humans. In this review, we will analyze and discuss new evidence supporting an important role for the CB chemoreceptor in the progression of autonomic and cardiorespiratory alterations induced by heart failure, obstructive sleep apnea, chronic obstructive pulmonary disease and metabolic syndrome.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Feature-3
content type line 23
ObjectType-Review-2
ISSN:0717-6287
0716-9760
0717-6287
DOI:10.1186/s40659-016-0073-8